Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy.

[1]  A. Bergamini,et al.  Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy. , 2008, AJR. American journal of roentgenology.

[2]  F. Schick,et al.  Quantification of Pancreatic Lipomatosis and Liver Steatosis by MRI: Comparison of In/Opposed-Phase and Spectral-Spatial Excitation Techniques , 2008, Investigative radiology.

[3]  Hyeonjin Kim,et al.  Comparative MR study of hepatic fat quantification using single‐voxel proton spectroscopy, two‐point dixon and three‐point IDEAL , 2008, Magnetic resonance in medicine.

[4]  N. Barzilai,et al.  Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. , 2007, American journal of physiology. Endocrinology and metabolism.

[5]  X. Papademetris,et al.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[6]  Michael Roden,et al.  Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[7]  F. Schick,et al.  Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat‐selective MRI and volume‐localized 1H‐MR spectroscopy , 2006, Magnetic resonance in medicine.

[8]  K. Lindor,et al.  Nonalcoholic fatty liver disease , 2005, Canadian Medical Association Journal.

[9]  J. Pawlotsky,et al.  Hepatitis C Virus-Induced Hepatocellular Steatosis , 2005, The American Journal of Gastroenterology.

[10]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[11]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[12]  C. Cobelli,et al.  Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. , 2004, Diabetes.

[13]  A. Häkkinen,et al.  Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. , 2004, Diabetes.

[14]  L. Bolondi,et al.  Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance , 2004, Gut.

[15]  M. Roden,et al.  The Role of Lipid Accumulation in Liver and Muscle for Insulin Resistance and Type 2 Diabetes Mellitus in Humans , 2004, Reviews in Endocrine and Metabolic Disorders.

[16]  D. Schoenfeld,et al.  Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation , 2004, Transplantation.

[17]  J. McHutchison,et al.  The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. , 2004, Journal of hepatology.

[18]  L. Rubbia‐Brandt,et al.  Steatosis affects chronic hepatitis C progression in a genotype specific way , 2004, Gut.

[19]  A. Lonardo,et al.  Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. , 2004, Gastroenterology.

[20]  T. Maeno,et al.  Mechanisms of increased insulin resistance in non‐cirrhotic patients with chronic hepatitis C virus infection , 2003, Journal of gastroenterology and hepatology.

[21]  Ekrem Orbay,et al.  Association of Nonalcoholic Fatty Liver Disease With Insulin Resistance: Is OGTT Indicated in Nonalcoholic Fatty Liver Disease? , 2003, Journal of clinical gastroenterology.

[22]  B. Neuschwander‐Tetri,et al.  Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone , 2003, Hepatology.

[23]  M. Manns,et al.  Effect of treatment with peginterferon or interferon alfa‐2b and ribavirin on steatosis in patients infected with hepatitis C , 2003, Hepatology.

[24]  V. Castellano-Megías,et al.  Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C , 2003, American Journal of Gastroenterology.

[25]  A. Häkkinen,et al.  Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy , 2002, AIDS.

[26]  J. George,et al.  Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response , 2002, Hepatology.

[27]  F. Wrba,et al.  Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. , 2002 .

[28]  R. Fontana,et al.  Noninvasive monitoring of patients with chronic hepatitis C , 2002 .

[29]  M. Roden,et al.  Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. , 2002, Diabetes.

[30]  D. Purdie,et al.  Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C , 2002, Gut.

[31]  K. Petersen,et al.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.

[32]  Vincent Lebon,et al.  The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. , 2002, Diabetes.

[33]  G. Pacini,et al.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.

[34]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[35]  K. C. Hong,et al.  Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. , 2001, Radiology.

[36]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[37]  A. Häkkinen,et al.  Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. , 2000, Diabetes.

[38]  F. Schick,et al.  Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. , 1999, American journal of physiology. Endocrinology and metabolism.

[39]  A. Czaja,et al.  Host- and disease-specific factors affecting steatosis in chronic hepatitis C , 1998 .

[40]  A. West,et al.  Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy , 1996, Hepatology.

[41]  J. Ludwig,et al.  The nomenclature of chronic active hepatitis: an obituary. , 1993, Gastroenterology.

[42]  C. Tiribelli,et al.  Fatty Infiltration of the Liver: Quantification by 1H Localized Magnetic Resonance Spectroscopy and Comparison with Computed Tomography , 1993, Investigative radiology.

[43]  M. Landau,et al.  Determination of plasma free fatty acids, free cholesterol, cholesteryl esters, and triacylglycerols directly from total lipid extract by capillary gas chromatography. , 1990, Analytical biochemistry.

[44]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[45]  A. Lim.  Letters to the editor: 1H MR spectroscopy in the evaluation of the severity of chronic liver disease , 2003 .

[46]  C. Thomsen,et al.  Quantification of liver fat using magnetic resonance spectroscopy. , 1994, Magnetic resonance imaging.